Skip to main content
icon for Casos de ciclosporíase nos EUA até 31 de julho?

Casos de ciclosporíase nos EUA até 31 de julho?

icon for Casos de ciclosporíase nos EUA até 31 de julho?

Casos de ciclosporíase nos EUA até 31 de julho?

$50,926 Vol.

31 jul 2026
Polymarket

$50,926 Vol.

Polymarket

5000+

$10,227 Vol.

Sim

7500+

$199 Vol.

Não

10.000+

$17,235 Vol.

Não

1800+

$3,663 Vol.

Sim

2000+

$5,096 Vol.

Sim

2500+

$7,808 Vol.

Sim

3000+

$6,697 Vol.

Sim

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.A major 2026 cyclosporiasis outbreak has driven elevated U.S. case counts through the typical May–July seasonal peak, with CDC confirming domestically acquired infections across multiple states linked primarily to contaminated fresh produce such as lettuce. As of late July, Michigan alone reported over 10,000 cases, while a single multistate cluster tied to Taco Bell locations exceeded 1,644 illnesses; Washington and other states added dozens more. These totals far surpass historical baselines of 200–1,000 annual illnesses from roughly a dozen outbreaks. Official CDC surveillance data through July 31 will incorporate delayed laboratory reports and interviews, with final national figures subject to revision. Traders monitoring resolution should watch for any CDC updates on total confirmed cases meeting the market’s geographic and temporal criteria.

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
Volume
$50,926
Data de Término
31 jul 2026
Mercado Aberto
Jul 14, 2026, 9:55 PM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.

Resultado proposto: Sim

Sem contestação

Resultado final: Sim

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.A major 2026 cyclosporiasis outbreak has driven elevated U.S. case counts through the typical May–July seasonal peak, with CDC confirming domestically acquired infections across multiple states linked primarily to contaminated fresh produce such as lettuce. As of late July, Michigan alone reported over 10,000 cases, while a single multistate cluster tied to Taco Bell locations exceeded 1,644 illnesses; Washington and other states added dozens more. These totals far surpass historical baselines of 200–1,000 annual illnesses from roughly a dozen outbreaks. Official CDC surveillance data through July 31 will incorporate delayed laboratory reports and interviews, with final national figures subject to revision. Traders monitoring resolution should watch for any CDC updates on total confirmed cases meeting the market’s geographic and temporal criteria.

This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
Volume
$50,926
Data de Término
31 jul 2026
Mercado Aberto
Jul 14, 2026, 9:55 PM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by July 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.

Resultado proposto: Sim

Sem contestação

Resultado final: Sim

Cuidado com os links externos.

Frequently Asked Questions

"Casos de ciclosporíase nos EUA até 31 de julho?" is a prediction market on Polymarket with 7 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "5000+" at 100%, followed by "1800+" at 100%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 100¢ implies that the market collectively assigns a 100% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "Casos de ciclosporíase nos EUA até 31 de julho?" has generated $50.9K in total trading volume since the market launched on Jul 14, 2026. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "Casos de ciclosporíase nos EUA até 31 de julho?," browse the 7 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "Casos de ciclosporíase nos EUA até 31 de julho?" is "5000+" at 100%, meaning the market assigns a 100% chance to that outcome. The next closest outcome is "1800+" at 100%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "Casos de ciclosporíase nos EUA até 31 de julho?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.